3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase NA
2
Phase 4
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
52
Neoplasms, Plasma Cell
5
Neoplasms
4
Lymphoma
4
Waldenstrom Macroglobulinemia
3
Recurrence
3
Hematologic Neoplasms
3
Prostatic Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Breast Neoplasms
2
Bone Neoplasms
2
Back Pain
2
Venous Thromboembolism
1
Stomatitis
1
Skin Neoplasms
1
Renal Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia, Pneumococcal
1
Pneumococcal Infections
1
Peripheral Nervous System Diseases
1
Pain
1
Osteoporosis
1
Osteonecrosis
1
Osteolysis
1
Myeloproliferative Disorders
1
Multiple Sclerosis
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cytokine Release Syndrome
×
Plasma cell
×
Clear all
NCT07609940
2026-05-27
POPLIN
Regeneron Pharmaceuticals
Phase 4
Not yet recruiting
30 enrolled